AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ATORVASTATIN 10 Mg ;

11 registrations across 1 African market— 11 active

Markets with ATORVASTATIN 10 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Atcolipox 10 mg
Chewable Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
Rostatine 10mg
Film Coated Tablets
🇪🇬EgyptAdwiaactive
Borgastatin 10mg
Tablets
🇪🇬EgyptBorg Pharmaceutical Industriesactive
Hipolixavast 10 mg
Chewable Tablets
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Lipitor* 10mg
Film Coated Tablets
🇪🇬EgyptViatris Egyptactive
Rostatine 10mg
Film Coated Tablets
🇪🇬EgyptAdwiaactive
Dawatovast 10 mg
Chewable Tablets
🇪🇬EgyptDawaa pharmaceuticals companyactive
Hipolixavast 10 mg
Chewable Tablets
🇪🇬EgyptEgyptian Group for Pharmaceutical Industries - EGPIactive
Dawatovast 10 mg
Chewable Tablets
🇪🇬EgyptDawaa pharmaceuticals companyactive
Atcolipox 10 mg
Chewable Tablets
🇪🇬EgyptATCO Pharma for Pharmaceutical Industriesactive
ANTICHOL 10mg
Film Coated Tablets
🇪🇬Egyptjedco international pharmaceuticalsactive

ATORVASTATIN 10 Mg ; in Africa — Regulatory Overview

ATORVASTATIN 10 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.